The Drug War Theatre is in Latin America
The International Network of People who Use Drugs (INPUD), Psicotropicus, the Brazilian Drug Policy Center (organizer) and the Brazilian Association for Social Studies of Psychoactive Substances (ABESUP) (local organizer), with support from the Drug Abuse Study and Therapy Center (CETAD/UFBA) and the Interdisciplinary Study Group of Psychoactive Substances of the Philosophy and Social Sciences Faculty of Federal University Bahia (GIESP/FFCH/UFBA) are pleased to announce the launch of the Latin American Network of People who Use Drugs (LANPUD) on the 25th and 26th of October 2012, in Salvador, Bahia, Brazil. The event will take place at the Leopoldo Amaral Auditorium of Escola Politécnica of Federal University of Bahia (UFBA), Rua Prof. Aristides Novis, No. 2 , Federação.
Some 30 users and former users from Argentina, Uruguay, Bolivia, Peru, Colombia, Mexico, Costa Rica and Brazil will present a comprehensive view of drug policy and drugs users’ organization in their countries at the conference “The Drug War Theatre is located in Latin America”, which will be held on the 25th of October 2012. On the second day, the organizers, guests and prospective members of the network will meet to set its course and address its organizational and operational issues.
The deepest need to set up this network comes from the fact that no group of oppressed people has ever achieved liberation without the involvement and organization of those directly affected by that oppression. The Latin American Network of People who Use Drugs (LANPUD) is here to change once and for all the uninformed, obsolete and prejudiced mentality regarding plants and drugs that have been classified as illegal.
The only way to solve our societies’ psychoactive substances problematic use and the growing violence born of archaic and ineffective drug policies is through evidence-based policies that respect human rights and dignity of people who use drugs. We are part of the solution, not of the problem.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.